Report Date,2019-06-30 00:00:00,2019-09-30 00:00:00,2019-12-31 00:00:00,2020-03-31 00:00:00,2020-06-30 00:00:00,2020-09-30 00:00:00,2020-12-31 00:00:00,2021-03-31 00:00:00,2021-06-30 00:00:00,2021-09-30 00:00:00,Company_Name
Sales,464.7,457.7,447.7,420.1,532.2,478.9,330.9,311.5,393.8,330.4,NATCOPHARM
Expenses,269.0,320.7,321.0,301.5,359.6,388.5,252.7,235.1,280.2,281.0,NATCOPHARM
Other Income,20.4,33.9,30.9,38.6,19.9,27.2,24.9,29.1,12.3,40.3,NATCOPHARM
Depreciation,21.6,21.6,25.1,29.8,27.6,28.4,29.4,29.8,33.1,34.2,NATCOPHARM
Interest,6.2,5.7,5.2,3.5,3.3,2.7,3.0,2.3,1.8,3.2,NATCOPHARM
Profit before tax,188.3,143.6,127.3,123.9,161.6,86.5,70.7,73.4,91.0,52.3,NATCOPHARM
Tax,40.6,21.4,23.7,22.9,34.9,15.6,16.0,16.2,15.8,-1.3,NATCOPHARM
Net profit,147.7,122.2,103.6,101.0,126.7,70.9,54.7,57.2,75.2,53.6,NATCOPHARM
Operating Profit,195.7,137.0,126.7,118.6,172.6,90.4,78.2,76.4,113.6,49.4,NATCOPHARM
